🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study valuates the safety and efficacy of treatment with 3% Diclofenac...
Status
Completed
Location
Barzilai Medical Center
Start Date
2007-06
Trial ID
NCT00484120
Treatments Being Tested
Vitamin D(Vit D) is a pro-differentiation agent that enhances the accumulat...
Status
Completed
Location
Dong-A University
Start Date
2014-05
Trial ID
NCT02976727
Hallux rigidus and hallux valgus are chronic forefoot conditions associated...
Status
Terminated
Location
Midwest Orthopaedics at Rush
Start Date
2019-10-20
Trial ID
NCT04103814
Treatments Being Tested
The purpose of this study is to determine if 0.5% Ivermectin Cream is a saf...
Status
Completed
Location
Arkansas Pediatric Clinic
Start Date
2010-03
Trial ID
NCT01068158
Treatments Being Tested
The purpose of this study is to clinically evaluate the efficacy, safety as...
Status
Completed
Location
University of California Davis
Start Date
2014-10
Trial ID
NCT02601105
Treatments Being Tested
This is a phase 2 study to investigate the safety and efficacy of PAC-14028...
Status
Completed
Location
Chung-ang University Hospital
Start Date
2015-10
Trial ID
NCT02757729
Treatments Being Tested
This is a phase II, double blind study with ZEP-3NA 0.1% or 1% vs. vehicle-...
Status
Unknown
Location
Ha'Emek MC
Start Date
2019-12-29
Trial ID
NCT04307862
Treatments Being Tested
The purpose of this study is to compare the effectiveness of two different ...
Status
Completed
Location
Meriden Research
Start Date
2007-08
Trial ID
NCT00641953
This is a phase 2 randomized controlled trial testing the effect of topical...
Status
Completed
Location
Henry Ford Hospital
Start Date
2017-12-20
Trial ID
NCT03223350
Treatments Being Tested
The purpose of this first in human and proof of concept study is to charact...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2017-12-15
Trial ID
NCT03333694
Treatments Being Tested